U
CO

UBS’s Global Cord Blood Corporation CO Stock Holding History

UBS’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$16K Buy
+3,244
New +$15.7K ﹤0.01% 8307
2014
Q1 		– Sell
-5,001
Closed -$20K – 11094
2013
Q4 		$20K Buy
+5,001
New +$19.9K ﹤0.01% 8172

Other funds holding CO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CCM
Cortex Capital Management Fort Worth, Texas $86.4M AUM 1.54% 1-Year Est. Return
MCM
McKinley Capital Management Anchorage, Alaska $571M AUM 36.44% 1-Year Est. Return
EMR
Errol M. Rudman $148M AUM 19.65% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
MYAM
Meiji Yasuda Asset Management Tokyo, Japan $2B AUM 22.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS's CO Position: Q3 2014 in Review

UBS opened a new position in Global Cord Blood Corporation (CO) in Q3 2014: 3,244 shares worth $16K. The stake represents ﹤0.01% of the portfolio and ranks #8307 among its holdings. This is a return to the name: UBS previously reported a position in CO as recently as Q4 2013.

UBS first reported a position in CO in Q4 2013 and has held it in 2 quarters since. The position peaked at $20K in Q4 2013. 29 funds tracked by Wall St. Rank hold CO as of Q3 2014.

  • UBS held 3,244 shares of Global Cord Blood Corporation worth $16K as of Q3 2014.
  • Global Cord Blood Corporation was a new UBS position in Q3 2014.
  • Global Cord Blood Corporation made up ﹤0.01% of UBS's portfolio in Q3 2014, its #8307 holding.
  • UBS first reported a position in Global Cord Blood Corporation in Q4 2013 and has held it in 2 quarters since.
  • UBS's Global Cord Blood Corporation position peaked at $20K in Q4 2013.
  • 29 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.